RECEPTOR MEDIATED T AND B CELL ACTIVATION
受体介导的 T 细胞和 B 细胞激活
基本信息
- 批准号:2463770
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Receptor-mediated activation was analyzed in T and B lymphocytes from
normal mice and from mice infected with the MAIDS-inducing defective
murine leukemia virus. Several weeks after viral infection, the
proliferative responses of T and B cells to cross-linking of TCR and
sIg respectively were significantly reduced despite the expression of
normal surface levels of these receptors by most T and B cells. To
analyze early signaling events in these cells, [Ca2+]i was measured in
response to surface receptor cross-linking. The [Ca2+]i responses of
both T and B cells from MAIDS-infected mice were decreased. B cell
responses to sIg cross-linking were further analyzed by examining
protein tyrosine phosphorylation induced by sIg cross-linking. It was
found that after virus infection, there was a progressive loss of
selected tyrosine phosphorylation events with conservation of other
events. The response defect in B cells from MAIDS mice is thus
reflected in selected alterations of tyrosine phosphorylation in
response to sIg signaling.
Costimulatory B7 molecules (B7-1 or CD80; and B7-2 or CD86) are known
to bind to T cell costimulatory receptors CD28 and CTLA4. Engagement
of CD28 is know to transduce signals in T cells that play a critical
role in T cell activation; however, little is known of the ability of
B7 molecules to themselves act as signal transducing molecules. The
effect of B7-1 and B7-2 crosslinking was assessed in the B cell
lymphoma BAL.17. Initial studies demonstrated that B7 crosslinking
induces AP-1 components including c-fos and c-jun, as demonstrated by
gel retardation and "super-shift" assays. These findings indicate that
B7 engagement by counter-receptors such as CD28 or CTLA4 may lead to
bidirectional effects, functioning to transduce signals in
B7-expressing cells such as B lymphocytes, in addition to signaling
CD28/CTLA4 positive T cells.
受体介导的活化在T和B淋巴细胞中进行了分析,
正常小鼠和感染MAIDS诱导缺陷型
鼠白血病病毒 病毒感染后几周,
T和B细胞对TCR交联的增殖反应,
sIg分别显著降低,尽管表达
大多数T和B细胞的这些受体的正常表面水平。 到
分析这些细胞中的早期信号传导事件,测量[Ca 2 +]i,
对表面受体交联的反应。 [Ca 2 +]i反应
MAIDS感染小鼠的T和B细胞均减少。 B细胞
对sIg交联的反应进一步分析,
由sIg交联诱导的蛋白酪氨酸磷酸化。 这是
发现病毒感染后,
选择的酪氨酸磷酸化事件,
事件 因此,来自MAIDS小鼠的B细胞中的应答缺陷是
反映在酪氨酸磷酸化的选择性改变中,
对sIg信号的响应。
共刺激B7分子(B7-1或CD 80;和B7-2或CD 86)是已知的
与T细胞共刺激受体CD 28和CTLA 4结合。 接合
已知CD 28的表达可以抑制T细胞中的信号,这些信号在T细胞中起着关键的作用。
在T细胞活化中的作用;然而,很少有人知道的能力,
B7分子本身充当信号转导分子。 的
在B细胞中评估B7-1和B7-2交联的作用
淋巴瘤BAL.17。 初步研究表明,B7交联
诱导AP-1组分,包括c-fos和c-jun,如
凝胶阻滞和“超位移”测定。 这些发现表明
B7与反受体如CD 28或CTLA 4的结合可能导致
双向效应,其功能是将信号
表达B7的细胞,如B淋巴细胞,除了信号传导外,
CD 28/CTLA 4阳性T细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R J HODES其他文献
R J HODES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R J HODES', 18)}}的其他基金
REGULATION OF LYMPHOCYTE PROLIFERATION AND CELL CYCLE PROGRESSION
淋巴细胞增殖和细胞周期进展的调节
- 批准号:
2463800 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNE RESPONSE GENE REGULATION OF IMMUNE RESPONSE IN VITRO
体外免疫反应的免疫反应基因调控
- 批准号:
4691763 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF LYMPHOCYTE PROLIFERATION AND REPLICATIVE CAPACITY
淋巴细胞增殖和复制能力的调节
- 批准号:
6100990 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNE RESPONSE GENE REGULATION OF THE IMMUNE RESPONSE IN VITRO
体外免疫反应的免疫反应基因调控
- 批准号:
3813459 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
-- - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
-- - 项目类别:














{{item.name}}会员




